세계의 산소 요법 시장 보고서(2025년)
Oxygen Therapy Global Market Report 2025
상품코드 : 1821692
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

산소 요법 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년 연평균 성장률(CAGR)은 10.5%를 나타낼 것으로 예측되고 460억 2,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 혁신적인 기기, 맞춤형 의약품, 연구개발 투자, 기후 변화 영향, 스포츠 및 피트니스 요인에 기인할 수 있습니다. 예측 기간의 주요 동향에는 가치 기반 의료 모델, 규제 발전, 환자 교육 프로그램, 대체 산소 공급 모델, 환자 중심 설계 등이 포함됩니다.

향후 5년간 10.5% 성장 전망은 이전 예측 대비 0.2% 소폭 하향 조정된 수치입니다. 이 같은 하향 조정은 주로 미국과 타국 간 관세 영향 때문입니다. 무역 긴장은 네덜란드와 중국에서 개발된 휴대용 산소 농축기와 고유량 비강 캐뉼라 시스템의 가격 상승을 유발하여 미국 병원들의 운영을 저해할 수 있으며, 이는 응급 치료 지연과 폐 재활 비용 증가로 이어질 수 있습니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 영향이 더욱 광범위하게 될 것입니다.

향후 담배 흡연율 증가가 산소 요법 시장을 촉진할 것으로 예상됩니다. 담배 흡연은 담배를 태워 연기를 흡입하는 행위로, 이 연기는 혈류로 흡수됩니다. 흡연 관련 호흡기 질환을 앓는 사람들은 종종 호흡 곤란과 혈중 산소 농도 저하를 경험합니다. 산소 요법은 보조 산소를 공급하여 호흡 문제를 완화하고 산소 포화도를 향상시키는 중요한 치료법입니다. 예를 들어, 2023년 12월 영국 정부 부문인 국민보건서비스(National Health Service)는 2022-23년 흡연과 관련된 입원 환자 수를 약 408,700명으로 보고했으며, 2021-22년 389,800명에서 4.8% 증가했습니다. 따라서 담배 흡연의 증가하는 유병률은 산소 요법 시장 성장을 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Oxygen therapy involves the administration of additional oxygen as part of the management of illnesses in individuals experiencing respiratory issues, preventing them from naturally obtaining sufficient oxygen due to various diseases and conditions. This therapeutic approach ensures that individuals with lung disorders or breathing difficulties receive the necessary oxygen to sustain bodily functions.

The primary categories of oxygen therapy products encompass oxygen delivery devices and oxygen source equipment. Oxygen delivery devices serve as secondary means of supplying oxygen to individuals unable to maintain a safe level of oxygen saturation. In oxygen therapy, devices for controlling and monitoring respiratory failure include nasal or transtracheal catheters and nasal cannula. These devices exhibit various levels of portability, ranging from stationary devices to portable ones, and find applications in conditions such as pneumonia, chronic obstructive pulmonary disease, asthma, obstructive sleep apnea, respiratory distress syndrome, cystic fibrosis, among others. The utilization of these devices extends across diverse settings, including hospitals, clinics, home care, and post-acute care facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The oxygen therapy market research report is one of a series of new reports from The Business Research Company that provides oxygen therapy market statistics, including the oxygen therapy industry global market size, regional shares, competitors with an oxygen therapy market share, detailed oxygen therapy market segments, market trends, and opportunities, and any further data you may need to thrive in the oxygen therapy industry. This oxygen therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The oxygen therapy market size has grown strongly in recent years. It will grow from $28.42 billion in 2024 to $30.88 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased prevalence of respiratory diseases and disorders, growing geriatric population globally, government initiatives promoting healthcare infrastructure, expansion of home healthcare services, increased smoking-related health issues.

The oxygen therapy market size is expected to see rapid growth in the next few years. It will grow to $46.02 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to innovative devices, personalized medicine, R&D investments, climate change impact, sports and fitness. Major trends in the forecast period include value-based care models, regulatory advances, patient education initiatives, alternative oxygen delivery models, patient-centric design.

The forecast of 10.5% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. hospitals by inflating prices of portable oxygen concentrators and high-flow nasal cannula systems developed in the Netherlands and China, resulting in delayed emergency care and higher pulmonary rehabilitation costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of tobacco smoking is anticipated to drive the growth of the oxygen therapy market in the future. Tobacco smoking involves burning tobacco to inhale its smoke, which is absorbed into the bloodstream. Individuals suffering from smoking-related respiratory diseases often face breathing difficulties and lower oxygen levels in their blood. Oxygen therapy is a vital intervention that provides supplemental oxygen, helping to alleviate breathing challenges and enhance oxygen saturation levels. For instance, in December 2023, the National Health Service, a UK-based government department, reported approximately 408,700 hospital admissions related to smoking in 2022-23, up from 389,800 in 2021-22, marking an increase of 4.8%. Thus, the increasing prevalence of tobacco smoking is fueling the growth of the oxygen therapy market.

The escalating incidence of respiratory disorders is expected to contribute to the expansion of the oxygen therapy market. Respiratory disorders, including lung diseases such as tuberculosis, lung cancer, mesothelioma, cystic fibrosis, and asthma, impact the respiratory system and often result in difficulties breathing. Oxygen therapy is a vital treatment for individuals with respiratory disorders, providing an additional supply of oxygen to relieve shortness of breath. According to a report by the American Lung Association in February 2023, over 34 million Americans suffer from chronic lung illnesses, including asthma and chronic obstructive pulmonary disease (COPD), emphasizing the growing demand for oxygen therapy.

Major players in the oxygen therapy market are responding to the increasing demand by developing innovative products. One notable development is the introduction of portable oxygen concentrators designed to cater to individuals with breathing-related disorders. These devices, such as the Oxlife Liberty launched by O2 Concepts in October 2022, are compact and lightweight, delivering continuous and adjustable oxygen supply. The Oxlife Liberty features advanced technology, including Dynamic Network Analysis (DNA) Technology, enhancing operational efficiency and providing a personalized oxygen therapy experience. The market's focus on innovation in portable oxygen concentrators reflects a commitment to meeting the diverse needs of patients with respiratory conditions.

Technological advancements are a prominent trend in the oxygen therapy market, with companies adopting new technologies to maintain their competitive edge. For example, Omron Healthcare introduced a portable oxygen concentrator in July 2022, utilizing Pressure Swing Adsorption (PSA) technology to ensure a continuous supply of oxygen at 5L per minute. This technology maintains oxygen efficiency and purity while enhancing the device's mobility for easier transport.

In January 2023, CAIRE Inc., a U.S.-based medical equipment manufacturing company, completed the acquisition of MGC Diagnostics, a move aimed at strengthening CAIRE Inc.'s diagnostic technologies portfolio to better serve patients with pulmonary diseases. MGC Diagnostics, a U.S.-based company specializing in oxygen therapy tools such as pulse oximeters, adds value to CAIRE Inc.'s commitment to providing comprehensive solutions in the field of respiratory care.

Major companies operating in the oxygen therapy market include Smiths Medical Inc., Hersill SL, Fisher & Paykel Healthcare Corporation Limited, Invacare Corporation, Teleflex Incorporated, Koninklijke Philips N.V., Drive Devilbiss International, Allied Healthcare Products Inc., Becton Dickinson and Company, General Electric Company, Getinge Group, Essex Industries Inc., Chart Industries Inc., Dragerwerk AG & Co. KGaA, Gas Control Equipment Group, Thermo Fisher Scientific Inc., OxyBand Technologies Inc., Nidek Medical Products Inc., Linde Healthcare, Taiyo Nippon Sanso Corporation, Inogen Inc., Heinen + Lowenstein GmbH & Co. KG, Messer Medical Austria GmbH, TECNO-GAZ S.p.A, HUM - Gesellschaft fur Homecare und Medizintechnik mbH, medicap homecare GmbH, GCE Holding AB, Salter Labs, Vyaire Medical Inc., CAIRE Inc., Precision Medical Inc., O2 Concepts LLC, AirSep Corporation

North America was the largest region in the oxygen therapy market in 2024. The regions covered in the oxygen therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the oxygen therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The oxygen therapy market consists of sales of pulse oximeters, oxygen flow meters, portable oxygen supply devices, nasal cannulas, simple masks, non-rebreather masks, continuous positive airway pressure, BiPAP, bag valve mask (ambu bag), endotracheal intubation, and mechanical ventilator. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Oxygen Therapy Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on oxygen therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for oxygen therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The oxygen therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Oxygen Therapy Market Characteristics

3. Oxygen Therapy Market Trends And Strategies

4. Oxygen Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Oxygen Therapy Growth Analysis And Strategic Analysis Framework

6. Oxygen Therapy Market Segmentation

7. Oxygen Therapy Market Regional And Country Analysis

8. Asia-Pacific Oxygen Therapy Market

9. China Oxygen Therapy Market

10. India Oxygen Therapy Market

11. Japan Oxygen Therapy Market

12. Australia Oxygen Therapy Market

13. Indonesia Oxygen Therapy Market

14. South Korea Oxygen Therapy Market

15. Western Europe Oxygen Therapy Market

16. UK Oxygen Therapy Market

17. Germany Oxygen Therapy Market

18. France Oxygen Therapy Market

19. Italy Oxygen Therapy Market

20. Spain Oxygen Therapy Market

21. Eastern Europe Oxygen Therapy Market

22. Russia Oxygen Therapy Market

23. North America Oxygen Therapy Market

24. USA Oxygen Therapy Market

25. Canada Oxygen Therapy Market

26. South America Oxygen Therapy Market

27. Brazil Oxygen Therapy Market

28. Middle East Oxygen Therapy Market

29. Africa Oxygen Therapy Market

30. Oxygen Therapy Market Competitive Landscape And Company Profiles

31. Oxygen Therapy Market Other Major And Innovative Companies

32. Global Oxygen Therapy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Oxygen Therapy Market

34. Recent Developments In The Oxygen Therapy Market

35. Oxygen Therapy Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기